SMS Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 1,614.82 million compared to INR 1,488.04 million a year ago. Revenue was INR 1,629.73 million compared to INR 1,510.19 million a year ago. Net income was INR 114.8 million compared to INR 37.64 million a year ago. Basic earnings per share from continuing operations was INR 1.36 compared to INR 0.44 a year ago. Diluted earnings per share from continuing operations was INR 1.36 compared to INR 0.44 a year ago.
For the nine months, sales was INR 4,634.65 million compared to INR 3,726.26 million a year ago. Revenue was INR 4,662.79 million compared to INR 3,762.55 million a year ago. Net income was INR 325.47 million compared to net loss of INR 105.7 million a year ago. Basic earnings per share from continuing operations was INR 3.84 compared to basic loss per share from continuing operations of INR 1.25 a year ago. Diluted earnings per share from continuing operations was INR 3.84 compared to diluted loss per share from continuing operations of INR 1.25 a year ago.